• Children with cystic fibrosis undergoing lung transplant harbour multiple subpopulations of M. abscessus.
Introduction
Mycobacterium abscessus is a nontuberculous mycobacteria (NTM) which has recently emerged as a major pathogen in cystic fibrosis (CF) patients 1 . Infection with M. abscessus is associated with poor clinical outcomes, particularly in conjunction with lung transplantation 2 . Treatment is challenging due to the intrinsic resistance of M. abscessus to many classes of antibiotics 3 , along with certain genotypes drastically altering the efficacy of antibiotic courses 4 . The antimicrobial resistance (AMR) profile of isolates is highly relevant for treatment, but current diagnostic work mainly uses isolates from sputum, which may not reflect the full range of genetic diversity within the patient and therefore fail to recover the true AMR profile.
Minority variants from WGS have been used to infer the presence of multiple subpopulations (subclones) in longitudinal sputum isolates of M. abscessus 5 
. However, it remains an open question
whether patients harbour further genetic diversity within the lung that is not sampled by sputum. The lung is known to be capable of harbouring considerable pathogen diversity in chronic infections. For example, M. tuberculosis has been shown to exist as multiple subpopulations with different AMR profiles 6 . Furthermore, the relevance of this genetic diversity for treatment is not yet known.
For this reason, we investigated longitudinal isolates from two patients infected with M. abscessus subsp. abscessus undergoing lung transplant at Great Ormond Street Hospital (Figure 1 ), and identified variable genomic positions within samples (single nucleotide variants, SNVs). By including isolates from sputum samples but also biologically important compartments such as pleural fluid, lung tissue, and swabs from chest wounds, we aimed to establish the extent and significance of withinpatient variation in M. abscessus for this vulnerable group. 
Methods

Patient cohort and sample collection
Great Ormond Street Hospital (GOSH) is a large regional centre for paediatric CF patients and the largest paediatric lung transplant centre in the UK. The two patients in this study (Patient 1 and Patient 2) were from other CF centres and were seen at GOSH for a transplant assessment, during the lung transplant procedure and post-transplant (Table 1) . Both patients in this study underwent regular respiratory microbiological diagnostic investigations, including specific stain and culture for mycobacteria on sputum pre-and post-transplant and explanted lung tissue, bronchoalveolar lavage, pleural fluid and clamshell incision wound swabs post-transplant. All further microbiological investigations were carried out on 'sweeps' from pure culture plates. All M. abscessus isolates cultured in our laboratory are identified to sub-species level by PCR and sequencing of hsp65 and rpoB genes and inducible macrolide resistance predicted by PCR and sequencing of the erm(41) gene as previously described 7 . VNTR profiles were obtained for selected isolates as previously described 8 . Phenotypic sensitivity data was obtained from the mycobacterial reference laboratory (Table 3) .
Demographic and clinical data were extracted from the Patient Administration System (PIMS) and microbiological data from the Laboratory Information Management system (OMNI-client ISS) using SQL (structured query language) databases and Excel spreadsheets. Additional sources of information included CF and transplantation databases. Details of antimicrobial therapy administered prior to transplantation was provided by the referring CF centres. All investigations were performed in accordance with the Hospitals Research governance policies and procedures. 16 isolates from Patient 1 and 16 isolates from Patient 2 underwent DNA extraction as previously described 8 with the addition of a bead beating step. Total DNA concentration was determined using the Qubit high-sensitivity (HS) assay kit (Thermofisher) and a sequencing library was prepared from 50 ng of DNA using the Nextera Library Preparation kit (Illumina). Post-PCR clean-up was carried out using Ampure XP beads (Beckman). Library size was validated using the Agilent 2200 TapeStation with Agilent D1000 ScreenTape System and 150bp paired-end reads were sequenced on a NextSeq 550 system (Illumina). Raw sequencing reads have been deposited on ENA (Study Accession PRJEB28875) as well as two assemblies used as 'de novo references' (see below).
Whole genome sequencing
Sequence data analysis
Initial variable nucleotide tandem repeat (VNTR) typing carried out as described previously 8, 9 suggested the possibility of mixed infections, based on results intermediate between VNTR I and the closely related VNTR I* profile (differing at one locus). A preliminary mapping of all isolates to the standard M. abscessus strain ATCC 19977 chromosome (NCBI Accession: CU458896.1) showed that the mean coverage at 10X was ~91%, contrasted with >99% for a representative set of VNTR II isolates from another patient sequenced according to the same protocol (not shown). In order to ensure we captured as much of the genetic diversity as possible, we therefore adopted a hybrid de novo and mapping approach. We selected the first isolate (temporally) for each patient and performed de novo assembly with Spades v3.10.0 with the --careful switch and otherwise default parameters 10 .
After removing contigs with <10,000 bases to reduce the possibility of including small mobile genetic elements, this first de novo assembly was used as a new reference to map raw reads from other isolates using bwa mem v0.7.12 with default parameters 11 . This produced 'de novo references' for Patient 1 and Patient 2 containing 5.17Mb and 5.28Mb respectively (Table 1) 
Variant identification and clustering analysis
In brief, the mapping file was sorted and indexed using picard v1.130, then GATK v3.30 was used to create a combined variant call format (VCF) file for each patient. Each position required a mapping depth > 30 in all samples from a patient to be included in downstream analysis. We manually inspected the 'self-mapping' of the reads from the first temporal sample to its own de novo assembly using IGV v2.4.10 13 to identify small regions where mapping was problematic. We removed SNVs within isolated regions where the self-mapping had unexpected peaks in SNVs where the reference allele fraction from the self-mapping reads was < 5%.
As noted by Bryant et al. 5 , patterns of linkage of variants in for M. abscessus can be suggestive of the existence of subpopulations. We aimed to establish a conservative lower bound for the number of clonal subpopulations within a patient, inferring their existence from the linkage patterns of variant frequencies across all samples. We note that patterns of linkage disequilibrium can also occur due to recombination. We therefore attempted to remove local recombination in our analysis. Using the SNVs obtained via the mapping and filtering methods described above, we hierarchically clustered SNVs using Ward's minimum variance criterion 14 applied to Euclidean distances between allele frequencies with a dissimilarity threshold of 1 to define clusters. We removed clusters containing <4
SNVs. We also removed putative local recombination regions by removing clusters where the SNVs were distributed within a total range < 100,000bp (corresponding to a threshold of ~2% of the total length of the M. abscessus genome).
In general, the inference of haplotype frequencies using variant frequencies from short sequencing reads for a microbial population undergoing recombination is a complex problem 15 . However, as we are not attempting to comment on abundances of subpopulations but only their presence, we did not need to infer haplotype frequencies.
Observing n distinct clusters of variants within a patient over time (i.e. allele frequencies that co-vary in step with each other) means that there must be at least n bacterial haplotypes within the population producing these patterns. This fact holds even when recombination is present. Therefore, observing distinct clusters of linked variants tells us that distinct subpopulations of M. abscessus exist within individual samples.
Results
Individuals harbour extensive variation
We observed multiple positions in the M. abscessus genome which varied between different isolates within a patient over time (total variable positions used for clustering across all isolates, patient 1: 54 positions, patient 2: 64 positions), although isolates remained highly similar on average and were clearly the same infecting strain (mean inter-isolate SNV distances patient 1: 2.07 +/-0.92 SNVs, patient 2: 1.96 +/-1.81 SNVs). Subsets of these SNVs showed patterns of linkage across the M.
abscessus genome (Figure 2a ). Similar clustered patterns of linked SNVs could also arise due to recombination, but the final groups of clustered SNVs were spread across the genome suggesting that multiple subclones were present. Even if recombination were present, leading to mixtures of clusters (i.e. different haplotypes), then the observed abundance patterns still required multiple subclones. A neighbour-joining tree produced from distances between isolates based on these allele frequencies suggested the presence of multiple subclones (Figure 2b ). 
Within-patient variation includes antimicrobial resistance mutations
Macrolide resistance in M. abscessus is driven by mutations at well-established positions in the rrl gene. Both patients received macrolides almost continuously throughout the six months prior to transplant (patient 1: oral azithromycin, patient 2: oral clarithromycin). While initial isolates taken earlier in treatment were susceptible, we observed that resistance alleles at these positions (C/G) increased in abundance over time ( Figure 3) . Notably, all sputum isolates from patient 1 showed a susceptible allele at position 2059 whereas isolates from pleural fluid and clamshell incision wound swabs carried a resistance allele (A2059C, Figure 3a ). There was also substantial variation within sets of isolates taken on the same day. For example, three isolates from different samples of lymph node tissue taken on the day of transplant for patient 2 showed completely different macrolide resistance profiles, most striking at position 2058 (Figure 3b ). These positions were not among the SNVs clustered into subpopulation structure clusters in patient 2, but rrl 2059 was part of cluster 1.D in patient 1, demonstrating that these resistance alleles can arise spontaneously but also persist linked to genetic background. We also observed variable positions in the rrs gene in both patients (Figure 4 ). The rrs gene codes for 16S rRNA and is often a site of the emergence of aminoglycoside resistance (e.g. to amikacin), particularly the last few 100bp of the gene where the secondary structure of the rRNA can be affected by multiple mutations 16 . The de novo reference assembly for the gene in both patients was identical to the previously characterised sequence from amikacin-resistant M. abscessus 16, 17 , which was consistent with the measured AMR phenotype of the first sputum sample in Patient 2 but not Patient 1 (Table 3 ). Subsequently, the patient_1_S2 isolate from lung tissue on the day of transplant had a different allele at position 1174 (C→T; Figure 4 ), and was partially resistant when phenotyped (Table   3 ), suggesting this mutation may have been involved in this resistance. In Patient 2, we observed both A and G at position 1374, corresponding to the A1400G mutation which confers high-level amikacin resistance in M. tuberculosis 18 . The G allele was dominant by the end of treatment, suggesting that it may have conferred higher resistance and/or been an important compensatory mutation.
Other sites also showed high levels of variation in both patients. After sorting SNVs by the standard deviation of the reference allele fraction across isolates ( Supplementary Dataset 1) , the most highly tended to be more similar to the initial sputum isolate used as a reference, even for Patient 1 where 3/3 subsequent sputum isolates were post-transplant (immunosuppressed). This also suggests that non-sputum isolates harboured additional diversity that was not well-sampled using sputum.
Sputum samples do not reflect overall within-patient diversity
Discussion
In this retrospective study we sought to establish the extent of within-patient variability of M.
abscessus in two patients who developed severe complications following lung transplant as part of treatment for CF. We used WGS to characterise this variability in isolates from longitudinal clinical samples, and were able to reveal patterns of linkage of SNVs consistent with the presence of multiple subpopulations within patients.
While isolates from the same patient were similar -for example, all inter-isolate distances for the same patient were within the threshold of 25 SNVs previously suggested for inferring potential transmission events 24 -this does not mean that the variation is not clinically significant. We have demonstrated that within-patient variation can contain biologically and clinically important variation.
Notably, we observed that variation at the rrl 2058/2059 positions, associated with macrolide resistance, developed over the course of treatment. We observed extensive variation in lung tissue isolates taken from Patient 41 prior to and on the day of transplant (i.e. before the patient was immunosuppressed). Isolates from Patient 1 samples taken prior to and on the day of transplant displayed no variation at these positions, so presumably the phenotypic macrolide resistance reported in these samples at this time was due entirely to inducible resistance conferred by erm(41).
Nonetheless, variation at rrl 2058/2059 positions was seen in later samples from this patient, suggesting that macrolide use still drives development of high-level macrolide resistance even in the presence of a functional erm(41) gene. We also observed variation in the rrs gene, another source of resistance to antibiotics targeting ribosomal function (e.g. amikacin), at both previously recorded and novel positions, including an allele that rose in dominance over the course of treatment in Patient 2 ( Figure 4 ).
Based on this data we would question how useful phenotypic testing of isolates recovered from a limited number of sputum isolates is for guiding antimicrobial therapy, as this strategy is unlikely to capture the diversity present in a single sample. Similarly, even though WGS is clearly a valuable tool, if restricted to the analysis of sputum isolates it may also fail to capture an accurate AMR profile of an infection. Previous studies on M. tuberculosis have shown that mycobacterial culture reduces the diversity recovered from sputum samples whether the culture was enriched in solid or liquid media 25, 26 . It is therefore possible that the diversity found across different sample sites in this study may have been present in the sputum sample, but was possibly lost in the culture step. For M.
tuberculosis, direct sequencing from sputum samples using capture-based enrichment methods has been shown to recover sample diversity not present in liquid culture 27 . Extending this to this case, it is possible that WGS at high depth applied directly to sputum samples could identify the variants detected between sample sites.
Other highly variable positions in genes involved in e.g. the regulation of ferric uptake (MAB_1678c) and the control of cell division (MAB_0347), are both of direct relevance for the survival of M.
abscessus across different physiological niches. In a chronic infection, mycobacteria must cope with considerable host stresses, including Fe starvation, which has been highlighted as enabling the persistence of M. tuberculosis in granulomas 28 . There is also, of course, phenotypic diversity due to expression. For example, colony morphotype has previously been suggested as providing a distinction between a 'non-invasive, biofilm-forming, persistent phenotype' (smooth) and an 'invasive phenotype that is unable to form biofilms' (rough), although recent work suggests both morphotypes are capable of aggregation and intracellular survival 29 . Further diversity may come from the subpopulations harboured at different locations within the patient's lung, which may therefore be an important source of diversity for clinically significant phenotypes.
There is also the possibility that this within-patient variability could lead to different transmission inferences, if different lineages of M. abscessus can be present in the lung together. However, the variation found within each of the two patients in this study, who were both infected with a clonal VNTR I strain, did not exceed the variation found between them.
Our findings suggest that the wider diversity present within patients chronically infected with M.
abscessus is not well-sampled with sputum, and that body site plays a role in subpopulation structure.
More widespread sampling of multiple body sites would provide a more accurate picture of the AMR profile of M. abscessus infecting a patient, and may be necessary to guide targeted antimicrobial therapy prior to transplant. However, in practical terms this would mean taking biopsies of lung and other tissue, which carries a significant clinical risk and would probably be unfeasible in the patient awaiting transplant. An alternative solution to improve patient management prior to transplant might rely on deep-sequencing of multiple sputum samples. Such a strategy might capture a sufficient fraction of the diversity seen with multiple body site sampling to provide accurate information about the presence of minor variants present in M. abscessus infections of CF patients, in particular those conferring AMR. 
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